Current role
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
Gina M. Mazzariello
General Counsel
Amylyx Pharmaceuticals, Inc. (AMLX)Equibles does not estimate personal net worth.
Get an email with a short summary when Amylyx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMLX alertsAbout Gina M. Mazzariello
Gina M. Mazzariello is recorded as General Counsel at Amylyx Pharmaceuticals, Inc. (AMLX). The newest filing on record that lists Gina M. Mazzariello as General Counsel at Amylyx Pharmaceuticals, Inc. (AMLX) is dated April 23, 2026. The proxy statement of Amylyx Pharmaceuticals, Inc. reports total compensation of $2,298,996 for Gina M. Mazzariello in fiscal 2024, including a base salary of $478,400. Disclosed compensation is on record for 3 fiscal years. Amylyx Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amylyx Pharmaceuticals, Inc. includes Joshua Cohen (CEO and Board Member), Justin Klee (CEO and Board Member), James Frates (CFO) and 2 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Amylyx Pharmaceuticals, Inc.
- Joshua Cohen CEO, Board Member
- Justin Klee CEO, Board Member
- James Frates CFO
- George Mclean Milne Jr Board Member
- Paul Fonteyne Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer and General Counsel | $478,400 | $2,298,996 |
| 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer and General Counsel | $460,000 | $3,013,676 |
| 2022 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer and General Counsel | $342,593 | $6,113,548 |
Recent activity
No call appearances or filed executive changes recorded yet.